Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SRT1720 HCl

Act 1001645-58-4 N-[2-[3-(Piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]quinoxaline-2-carboxamide, hydrochloride
N° du produit ABIN7233295

Aperçu rapide pour SRT1720 HCl (ABIN7233295)

Application

Activation (Act)

Chemical Name

N-[2-[3-(Piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]quinoxaline-2-carboxamide, hydrochloride
  • Fonction

    SIRT1 activator

    Attributs du produit

    Sirtuin1 (SIRT1) activator, EC1.5 = 0.16 μM, that reduces glucose levels and hyperinsulinemia in mouse and rat models of obesity. SRT1720 represses expression of circadian clock genes in vitro and in vivo. It inhibits vascular inflammation caused by angiotensin II-induced atherosclerosis and reverses abnormal mitochondrial function in primary neurons exposed to 20-HETE. Ameliorates hypoxic injury in pancreatic β-cells, and enhances ferroptosis in head and neck cancer cells.

    Pureté

    >98 %

    Formula

    C25H23N7OS•HCl

    Solubility

    Soluble in DMSO (up to at least 25 mg/ml)
  • Restrictions

    For Research Use only
  • Format

    Powder

    Stock

    -20 °C
  • Sujet

    SIRT 1933,Redox,Epigenetics,Apoptosis inhibitor,Mitochondrial function,Protein deacetylase,Oxidative stress,Cell death,Circadian rhythm,Diabetes,Kidney disease,Atherosclerosis,Inflammation,Posttranslational modification,Obesity,Chromatin

    Poids moléculaire

    506.0

    Numéro CAS

    1001645-58-4
Vous êtes ici:
Chat with us!